Introduction: Ketogenic therapy (KT) studies have focused in children older than 2 years and adults. Recently its efficacy in infants has been reported, but there are few studies in this age group.
Patients And Methods: We report a case series of nine newborn and children younger than 4 months of age with refractory epilepsy treated with KT.
EClinicalMedicine
February 2022